|
Status |
Public on Jul 31, 2017 |
Title |
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
High levels of LMO1 expression synergizes with MYCN to accelerate neuroblastomagenesis, enhance disease penetrance and promote widespread metastasis in zebrafish. Transcriptomic analysis of human neuroblasotma cells with programed expression of LMO1 vs vector control or neuroblastoma cells with differential endogenous LMO1 expression revealed that gene signitures affecting tumor cell-extracellular matrix interaction are significantly associated with high levels of LMO1 expression. Our findings provide compelling evidence for a major pathogenic role of LMO1 in MYCN-driven neuroblastoma.
|
|
|
Overall design |
Examination of transcriptiome profiles in LMO1 overexpression neuroblastoma cells
|
|
|
Contributor(s) |
Zhu S, Li H |
Citation(s) |
28867147 |
|
Submission date |
Nov 18, 2016 |
Last update date |
Jun 05, 2019 |
Contact name |
Hu Li |
E-mail(s) |
li.hu@mayo.edu
|
Organization name |
Mayo Clinic
|
Department |
Molecular Pharmacology & Experimental Therapeutics
|
Lab |
Systems Biology and Pharmacology
|
Street address |
200 First Street, Gonda Building G19-408
|
City |
Rochester |
State/province |
MN |
ZIP/Postal code |
55904 |
Country |
USA |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA354383 |
SRA |
SRP093679 |